Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors
NCT ID: NCT06969131
Last Updated: 2025-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2022-05-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Partial Nephrectomy for cT1 Tumors
NCT04213157
A Comparative Study Between Open and Robotic Partial Nephrectomy in Treatment of High Complex Renal Tumors.
NCT04537247
Oncological and Functional Outcomes of Laparoscopic Partial Nephrectomy in Renal Cell Carcinoma Stages T1 Versus T2a: Prospective Comparative Study.
NCT05486871
Efficacy of the Triangle Operation on Clinical Outcomes in Patients With Pancreatic Cancer
NCT05703139
Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy
NCT05134142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The trifecta metric includes three components: warm ischemia time (WIT) of ≤ 25 minutes or cold ischemia time (CIT) of ≤ 60 minutes, negative surgical margins, and the absence of perioperative major complications. The pentafecta expands upon these criteria by adding two additional parameters: preservation of ≥ 90% of the estimated glomerular filtration rate (eGFR) and no progression in chronic kidney disease (CKD) stage within 12 months postoperatively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open Partial Nephrectomy
Patients underwent open partial nephrectomy.
Open Partial Nephrectomy
Patients underwent open partial nephrectomy.
Laparoscopic Partial Nephrectomy
Patients underwent laparoscopic partial nephrectomy.
Laparoscopic Partial Nephrectomy
Patients underwent laparoscopic partial nephrectomy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Open Partial Nephrectomy
Patients underwent open partial nephrectomy.
Laparoscopic Partial Nephrectomy
Patients underwent laparoscopic partial nephrectomy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both sexes.
* Patients who diagnosed with clinical T1 or T2a N0M0 renal tumors who were suitable candidates for partial nephrectomy
Exclusion Criteria
* Anatomically unfavorable tumor location.
* Extensive encasement of the renal pedicle.
* Diffuse invasion of the renal vein or central collecting system.
* Adjacent organ invasion consistent with stage cT4 disease.
* Regional lymphadenopathy (stage cTxN1), or anticipated retention of less than 20% of total nephron mass.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South Valley University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omar Ahmad Mohammed Bakheet
Assistant Lecturer of Urology, Faculty of Medicine, South Valley University, Egypt.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
South Valley university
South Valley, Qena Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SVU/MED/URO016/2/22/5/400
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.